Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks.

× No keyword cloud information.

19 in total

1. Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers.

Authors: Anthony L McCall
Journal: Curr Diab Rep Date: 2007-10 Impact factor: 4.810

2. Classification and pharmacological management of obesity.

Authors: Sarah R Erlanger; Emily A Henson
Journal: P T Date: 2008-12

3. Rimonabant: more than an anti-obesity drug?

Authors: B Costa
Journal: Br J Pharmacol Date: 2007-01-22 Impact factor: 8.739

4. Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions.

Authors: Panayotis K Thanos; Roberto C Ramalhete; Michael Michaelides; Yianni K Piyis; Gene-Jack Wang; Nora D Volkow
Journal: Synapse Date: 2008-09 Impact factor: 2.562

5. Combination pharmaceutical therapies for obesity.

Authors: Kishore M Gadde; David B Allison
Journal: Expert Opin Pharmacother Date: 2009-04 Impact factor: 3.889

6. Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients.

Authors: Christopher T Dibble; Eli V Gelfand; Christopher P Cannon
Journal: Curr Atheroscler Rep Date: 2007-11 Impact factor: 5.113

Review 7. The endocannabinoid system: potential for reducing cardiometabolic risk.

Authors: Henry N Ginsberg; Stephen C Woods
Journal: Obesity (Silver Spring) Date: 2009-04-16 Impact factor: 5.002

8. Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice.

Authors: Gernot Riedel; Paola Fadda; Susan McKillop-Smith; Roger G Pertwee; Bettina Platt; Lianne Robinson
Journal: Br J Pharmacol Date: 2009-04 Impact factor: 8.739

Review 9. Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

Authors: Jennifer B Green; Mark N Feinglos
Journal: Curr Diab Rep Date: 2007-10 Impact factor: 4.810

10. Drugs associated with more suicidal ideations are also associated with more suicide attempts.

Authors: Henry T Robertson; David B Allison
Journal: PLoS One Date: 2009-10-02 Impact factor: 3.240